G. F. Ray

THE DIFFUSION OF NEW INDUSTRIAL PROCESSES

L. Nabseth, G. F. Ray, 2016 .

Determination of FGN-1 (an active metabolite of sulindac) in human plasma, urine, and feces by HPLC.

G. F. Ray, R. Lanman, R. Pamukcu, 1995, Journal of pharmaceutical and biomedical analysis.

A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results.

G. F. Ray, C. Fortin, R. Gimpelson, 2017, Journal of minimally invasive gynecology.